← Back to Search

Decision Support Tool for Chronic Kidney Disease

N/A
Recruiting
Led By Manjula Tamura, MD, MPH
Research Sponsored by VA Palo Alto Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >=65
Estimated GFR <25 ml/min/1.73m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group

Summary

"This trial will look at how a web-based tool can help people with advanced kidney disease make decisions about dialysis. It will measure if the tool reduces confusion and helps patients align their treatment choices with their

Who is the study for?
This trial is for individuals with advanced chronic kidney disease who are facing decisions about dialysis. The study seeks participants willing to use a web-based tool designed to support these decisions. Specific eligibility criteria details were not provided.
What is being tested?
The study is testing a web-based dialysis decision support tool, aiming to see if it helps reduce decisional conflict and improves alignment between patients' values and their chosen treatments. It also evaluates the tool's ease of use and satisfaction among users.
What are the potential side effects?
Since this trial involves a web-based decision support tool rather than medication or invasive procedures, traditional physical side effects are not expected. Any potential 'side effects' would likely relate to user experience issues such as frustration or confusion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
My kidney function is severely reduced.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Confidence in treatment decision
Decisional Conflict Scale (DCS)
Treatment choice
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Web-based dialysis decision support tool
Group II: ControlActive Control1 Intervention
Historical controls

Find a Location

Who is running the clinical trial?

VA Palo Alto Health Care SystemLead Sponsor
93 Previous Clinical Trials
58,127 Total Patients Enrolled
Manjula Tamura, MD, MPHPrincipal InvestigatorU.S. Department of Veterans Affairs - Palo Alto Health Care System
~17 spots leftby Sep 2026